共 50 条
- [31] Hallmarks of Resistance to Immune-Checkpoint InhibitorsCANCER IMMUNOLOGY RESEARCH, 2022, 10 (04) : 372 - 383Karasarides, Maria论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USACogdill, Alexandria P.论文数: 0 引用数: 0 h-index: 0机构: Immunai, New York, NY USA Univ Texas MD Anderson, Dept Immunol, Houston, TX USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USARobbins, Paul B.论文数: 0 引用数: 0 h-index: 0机构: Instil Bio, Dallas, TX USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USABowden, Michaela论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Translat Med, Cambridge, MA USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USABurton, Elizabeth M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson, Dept Surg Oncol, Houston, TX USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USAButterfield, Lisa H.论文数: 0 引用数: 0 h-index: 0机构: Parker Inst Canc Immunotherapy, San Francisco, CA USA Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USACesano, Alessandra论文数: 0 引用数: 0 h-index: 0机构: ESSA Pharma Inc, San Francisco, CA USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USAHammer, Christian论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, Dept Canc Immunol, San Francisco, CA USA Genentech Inc, Dept Human Genet, San Francisco, CA USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USAHaymaker, Cara L.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USAHorak, Christine E.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Global Drug Dev, Lawrenceville, NJ USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USAMcGee, Heather M.论文数: 0 引用数: 0 h-index: 0机构: City Hope Natl Med Ctr, Dept Radiat Oncol, Duarte, CA USA City Hope Natl Med Ctr, Dept Immunooncol, Beckmann Res Inst, Duarte, CA USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USAMonette, Anne论文数: 0 引用数: 0 h-index: 0机构: Lady Davis Inst Med Res, Montreal, PQ, Canada Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USARudqvist, Nils-Petter论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USASpencer, Christine N.论文数: 0 引用数: 0 h-index: 0机构: Parker Inst Canc Immunotherapy, Dept Informat, San Francisco, CA USA Univ Calif San Francisco, San Francisco, CA 94143 USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USASweis, Randy F.论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago, Dept Med, Sect Hematol Oncol, Chicago, IL 60637 USA Univ Chicago, Comm Immunol, Chicago, IL 60637 USA Univ Chicago, Comprehens Canc Ctr, Chicago, IL 60637 USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USAVincent, Benjamin G.论文数: 0 引用数: 0 h-index: 0机构: Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USAWennerberg, Erik论文数: 0 引用数: 0 h-index: 0机构: Inst Canc Res, London, England Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USAYuan, Jianda论文数: 0 引用数: 0 h-index: 0机构: Merck Res Labs, Early Oncol Dev Dept, Translat Oncol, Rahway, NJ USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USAZappasodi, Roberta论文数: 0 引用数: 0 h-index: 0机构: Weill Cornell Med, New York, NY USA Mem Sloan Kettering Canc Ctr, Ludwig Collaborat & Swim Amer Lab, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, New York, NY 10021 USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USALucey, Vanessa M. Hubbard论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USAWells, Daniel K.论文数: 0 引用数: 0 h-index: 0机构: Immunai, New York, NY USA Parker Inst Canc Immunotherapy, San Francisco, CA USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USALaVallee, Theresa论文数: 0 引用数: 0 h-index: 0机构: Parker Inst Canc Immunotherapy, San Francisco, CA USA Bristol Myers Squibb, Worldwide Med Oncol, Princeton, NJ USA
- [32] Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinomaNATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (04) : 199 - 214Braun, David A.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Harvard Med Sch, Boston, MA 02115 USA Broad Inst MIT & Harvard, Cambridge, MA 02142 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Flippot, Ronan论文数: 0 引用数: 0 h-index: 0机构: Gustave Roussy, Dept Med Oncol, Villejuif, France Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAVan Allen, Eliezer M.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Harvard Med Sch, Boston, MA 02115 USA Broad Inst MIT & Harvard, Cambridge, MA 02142 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAWu, Catherine J.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Harvard Med Sch, Boston, MA 02115 USA Broad Inst MIT & Harvard, Cambridge, MA 02142 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USAChoueiri, Toni K.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA Harvard Med Sch, Boston, MA 02115 USA Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
- [33] Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinomaNature Reviews Clinical Oncology, 2021, 18 : 199 - 214David A. Braun论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyZiad Bakouny论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyLaure Hirsch论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyRonan Flippot论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyEliezer M. Van Allen论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyCatherine J. Wu论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical OncologyToni K. Choueiri论文数: 0 引用数: 0 h-index: 0机构: Dana-Farber Cancer Institute,Department of Medical Oncology
- [34] Germline genetic association on efficacy of Immune-checkpoint inhibition in Metastatic Melanoma patientsJOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S264 - S264Ouwerkerk, W.论文数: 0 引用数: 0 h-index: 0机构: Amsterdam UMC, Amsterdam, Netherlands Amsterdam UMC, Amsterdam, NetherlandsChielie, S.论文数: 0 引用数: 0 h-index: 0机构: Amsterdam UMC, Amsterdam, Netherlands Amsterdam UMC, Amsterdam, NetherlandsBekkenk, M.论文数: 0 引用数: 0 h-index: 0机构: Amsterdam UMC, Amsterdam, Netherlands Amsterdam UMC, Amsterdam, NetherlandsVan Doorn, R.论文数: 0 引用数: 0 h-index: 0机构: LUMC, Leiden, Netherlands Amsterdam UMC, Amsterdam, NetherlandsBlank, C. U.论文数: 0 引用数: 0 h-index: 0机构: NKI, Amsterdam, Netherlands Amsterdam UMC, Amsterdam, NetherlandsHaanen, J. B.论文数: 0 引用数: 0 h-index: 0机构: NKI, Amsterdam, Netherlands Amsterdam UMC, Amsterdam, NetherlandsHospers, G. A.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Groningen, Groningen, Netherlands Amsterdam UMC, Amsterdam, NetherlandsKirchhoff, T.论文数: 0 引用数: 0 h-index: 0机构: NYU Langone Hlth, New York, NY USA Amsterdam UMC, Amsterdam, NetherlandsLuiten, R.论文数: 0 引用数: 0 h-index: 0机构: Amsterdam UMC, Amsterdam, Netherlands Amsterdam UMC, Amsterdam, Netherlands
- [35] Immune-checkpoint Inhibitor in clinical practiceANNALS OF ONCOLOGY, 2015, 26 : 69 - 69Fujiwara, Yutaka论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp, Dept Expt Therapeut, Kashiwa, Chiba, Japan Natl Canc Ctr Hosp, Dept Expt Therapeut, Kashiwa, Chiba, Japan
- [36] Immune-Checkpoint Blockade Therapy in LymphomaINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 15Kuzume, Ayumi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hematol, Kashiwa, Chiba 2778577, Japan Kameda Med Ctr, Dept Hematol, Kamogawa 2968602, Japan Natl Canc Ctr Hosp East, Dept Hematol, Kashiwa, Chiba 2778577, JapanChi, SungGi论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hematol, Kashiwa, Chiba 2778577, Japan Natl Canc Ctr Hosp East, Dept Hematol, Kashiwa, Chiba 2778577, JapanYamauchi, Nobuhiko论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hematol, Kashiwa, Chiba 2778577, Japan Natl Canc Ctr Hosp East, Dept Hematol, Kashiwa, Chiba 2778577, JapanMinami, Yosuke论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr Hosp East, Dept Hematol, Kashiwa, Chiba 2778577, Japan Natl Canc Ctr Hosp East, Dept Hematol, Kashiwa, Chiba 2778577, Japan
- [37] Type I interferon signaling pathway enhances immune- checkpoint inhibition in KRAS mutant lung tumorsPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (36)Fernandez-Garcia, Fernando论文数: 0 引用数: 0 h-index: 0机构: Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainFernandez-Rodriguez, Ana论文数: 0 引用数: 0 h-index: 0机构: Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainFustero-Torre, Coral论文数: 0 引用数: 0 h-index: 0机构: Ctr Nacl Invest Oncol, Bioinformat Unit, Madrid 28029, Spain Max Delbruck Ctr Mol Med, Helmholtz Assoc MDC, Berlin Inst Med Syst Biol BIMSB, D-13092 Berlin, Germany Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainPineiro-Yanez, Elena论文数: 0 引用数: 0 h-index: 0机构: Ctr Nacl Invest Oncol, Bioinformat Unit, Madrid 28029, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainWang, Haiyun论文数: 0 引用数: 0 h-index: 0机构: Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainLechuga, Carmen G.论文数: 0 引用数: 0 h-index: 0机构: Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainCallejas, Sergio论文数: 0 引用数: 0 h-index: 0机构: Ctr Nacl Invest Cardiovasc, Genom Unit, Madrid 28029, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainAlvarez, Rebeca论文数: 0 引用数: 0 h-index: 0机构: Ctr Nacl Invest Cardiovasc, Genom Unit, Madrid 28029, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainLopez-Garcia, Alejandra论文数: 0 引用数: 0 h-index: 0机构: Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainEsteban-Burgos, Laura论文数: 0 引用数: 0 h-index: 0机构: Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, Spain Lilly Espana, Med Dept, Oncol, Alcobendas 28108, Madrid, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainSalmon, Marina论文数: 0 引用数: 0 h-index: 0机构: Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, Spain Asociac Espanola Canc, Madrid 28045, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainSan Roman, Marta论文数: 0 引用数: 0 h-index: 0机构: Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainGuerra, Carmen论文数: 0 引用数: 0 h-index: 0机构: Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, Spain Inst Salud Carlos III, Ctr Invest Biomed Red Canc, Madrid 28029, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainAmbrogio, Chiara论文数: 0 引用数: 0 h-index: 0机构: Univ Torino, Mol Biotechnol Ctr, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainDrosten, Matthias论文数: 0 引用数: 0 h-index: 0机构: Inst Salud Carlos III, Ctr Invest Biomed Red Canc, Madrid 28029, Spain Univ Salamanca, CSIC, Ctr Invest Canc, Mol Mech Canc Program, Salamanca 37007, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainSantamaria, David论文数: 0 引用数: 0 h-index: 0机构: Univ Salamanca, CSIC, Ctr Invest Canc, Mol Mech Canc Program, Salamanca 37007, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainAl Shahrour, Fatima论文数: 0 引用数: 0 h-index: 0机构: Ctr Nacl Invest Oncol, Bioinformat Unit, Madrid 28029, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainDopazo, Ana论文数: 0 引用数: 0 h-index: 0机构: Ctr Nacl Invest Cardiovasc, Genom Unit, Madrid 28029, Spain Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Cardiovasc, Madrid 28029, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainBarbacid, Mariano论文数: 0 引用数: 0 h-index: 0机构: Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, Spain Inst Salud Carlos III, Ctr Invest Biomed Red Canc, Madrid 28029, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, SpainMusteanu, Monica论文数: 0 引用数: 0 h-index: 0机构: Inst Salud Carlos III, Ctr Invest Biomed Red Canc, Madrid 28029, Spain Univ Complutense Madrid, Fac Pharm, Dept Biochem & Mol Biol, Madrid 28040, Spain Hlth Res Inst San Carlos, Canc & Obes Grp, Madrid 28040, Spain Ctr Nacl Invest Oncol, Mol Oncol Program, Expt Oncol Grp, Madrid 28029, Spain
- [38] Hsp90β inhibition upregulates interferon response and enhances immune checkpoint blockade therapy in murine tumorsFRONTIERS IN IMMUNOLOGY, 2022, 13Rahmy, Sharif论文数: 0 引用数: 0 h-index: 0机构: Univ Notre Dame, Harper Canc Res Inst, Boler Parseghian Ctr Rare & Neglected Dis, Dept Biol Sci, Notre Dame, IN 46556 USA Univ Notre Dame, Integrated Biomed Sci Grad Program, Notre Dame, IN 46556 USA Univ Notre Dame, Harper Canc Res Inst, Boler Parseghian Ctr Rare & Neglected Dis, Dept Biol Sci, Notre Dame, IN 46556 USAMishra, Sanket J. J.论文数: 0 引用数: 0 h-index: 0机构: Univ Notre Dame, Warren Family Res Ctr Drug Discovery & Dev, Dept Chem & Biochem, Notre Dame, IN USA Univ Notre Dame, Harper Canc Res Inst, Boler Parseghian Ctr Rare & Neglected Dis, Dept Biol Sci, Notre Dame, IN 46556 USAMurphy, Sean论文数: 0 引用数: 0 h-index: 0机构: Univ Notre Dame, Harper Canc Res Inst, Boler Parseghian Ctr Rare & Neglected Dis, Dept Biol Sci, Notre Dame, IN 46556 USA Univ Notre Dame, Harper Canc Res Inst, Boler Parseghian Ctr Rare & Neglected Dis, Dept Biol Sci, Notre Dame, IN 46556 USABlagg, Brian S. J.论文数: 0 引用数: 0 h-index: 0机构: Univ Notre Dame, Warren Family Res Ctr Drug Discovery & Dev, Dept Chem & Biochem, Notre Dame, IN USA Univ Notre Dame, Harper Canc Res Inst, Boler Parseghian Ctr Rare & Neglected Dis, Dept Biol Sci, Notre Dame, IN 46556 USALu, Xin论文数: 0 引用数: 0 h-index: 0机构: Univ Notre Dame, Harper Canc Res Inst, Boler Parseghian Ctr Rare & Neglected Dis, Dept Biol Sci, Notre Dame, IN 46556 USA Univ Notre Dame, Integrated Biomed Sci Grad Program, Notre Dame, IN 46556 USA Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Tumor Microenvironm & Metastasis Program, Indianapolis, IN 46202 USA Univ Notre Dame, Harper Canc Res Inst, Boler Parseghian Ctr Rare & Neglected Dis, Dept Biol Sci, Notre Dame, IN 46556 USA
- [39] Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibitionCancer Immunology, Immunotherapy, 2019, 68 : 897 - 905Vylyny Chat论文数: 0 引用数: 0 h-index: 0机构: New York University School of Medicine,Laura and Issac Perlmutter Cancer CenterRobert Ferguson论文数: 0 引用数: 0 h-index: 0机构: New York University School of Medicine,Laura and Issac Perlmutter Cancer CenterDanny Simpson论文数: 0 引用数: 0 h-index: 0机构: New York University School of Medicine,Laura and Issac Perlmutter Cancer CenterEsther Kazlow论文数: 0 引用数: 0 h-index: 0机构: New York University School of Medicine,Laura and Issac Perlmutter Cancer CenterRebecca Lax论文数: 0 引用数: 0 h-index: 0机构: New York University School of Medicine,Laura and Issac Perlmutter Cancer CenterUna Moran论文数: 0 引用数: 0 h-index: 0机构: New York University School of Medicine,Laura and Issac Perlmutter Cancer CenterAnna Pavlick论文数: 0 引用数: 0 h-index: 0机构: New York University School of Medicine,Laura and Issac Perlmutter Cancer CenterDennie Frederick论文数: 0 引用数: 0 h-index: 0机构: New York University School of Medicine,Laura and Issac Perlmutter Cancer CenterGenevieve Boland论文数: 0 引用数: 0 h-index: 0机构: New York University School of Medicine,Laura and Issac Perlmutter Cancer CenterRyan Sullivan论文数: 0 引用数: 0 h-index: 0机构: New York University School of Medicine,Laura and Issac Perlmutter Cancer CenterAntoni Ribas论文数: 0 引用数: 0 h-index: 0机构: New York University School of Medicine,Laura and Issac Perlmutter Cancer CenterKeith Flaherty论文数: 0 引用数: 0 h-index: 0机构: New York University School of Medicine,Laura and Issac Perlmutter Cancer CenterIman Osman论文数: 0 引用数: 0 h-index: 0机构: New York University School of Medicine,Laura and Issac Perlmutter Cancer CenterJeffrey Weber论文数: 0 引用数: 0 h-index: 0机构: New York University School of Medicine,Laura and Issac Perlmutter Cancer CenterTomas Kirchhoff论文数: 0 引用数: 0 h-index: 0机构: New York University School of Medicine,Laura and Issac Perlmutter Cancer Center
- [40] Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibitionCANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (06) : 897 - 905Chat, Vylyny论文数: 0 引用数: 0 h-index: 0机构: NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USA NYU, Dept Populat Hlth & Environm Med, Sch Med, New York, NY 10016 USA NYU, Interdisciplinary Melanoma Cooperat Grp, Sch Med, New York, NY 10016 USA NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USAFerguson, Robert论文数: 0 引用数: 0 h-index: 0机构: NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USA NYU, Dept Populat Hlth & Environm Med, Sch Med, New York, NY 10016 USA NYU, Interdisciplinary Melanoma Cooperat Grp, Sch Med, New York, NY 10016 USA NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USASimpson, Danny论文数: 0 引用数: 0 h-index: 0机构: NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USA NYU, Dept Populat Hlth & Environm Med, Sch Med, New York, NY 10016 USA NYU, Interdisciplinary Melanoma Cooperat Grp, Sch Med, New York, NY 10016 USA NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USAKazlow, Esther论文数: 0 引用数: 0 h-index: 0机构: NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USA NYU, Dept Populat Hlth & Environm Med, Sch Med, New York, NY 10016 USA NYU, Interdisciplinary Melanoma Cooperat Grp, Sch Med, New York, NY 10016 USA NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USALax, Rebecca论文数: 0 引用数: 0 h-index: 0机构: NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USA NYU, Dept Populat Hlth & Environm Med, Sch Med, New York, NY 10016 USA NYU, Interdisciplinary Melanoma Cooperat Grp, Sch Med, New York, NY 10016 USA NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USAMoran, Una论文数: 0 引用数: 0 h-index: 0机构: NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USA NYU, Interdisciplinary Melanoma Cooperat Grp, Sch Med, New York, NY 10016 USA NYU, Dept Med, Sch Med, New York, NY 10016 USA NYU, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USAPavlick, Anna论文数: 0 引用数: 0 h-index: 0机构: NYU, Interdisciplinary Melanoma Cooperat Grp, Sch Med, New York, NY 10016 USA NYU, Dept Med, Sch Med, New York, NY 10016 USA NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USAFrederick, Dennie论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Canc Ctr, Massachusetts Gen Hosp, Ctr Melanoma, Boston, MA 02115 USA NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USABoland, Genevieve论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Canc Ctr, Massachusetts Gen Hosp, Ctr Melanoma, Boston, MA 02115 USA NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USASullivan, Ryan论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Canc Ctr, Massachusetts Gen Hosp, Ctr Melanoma, Boston, MA 02115 USA NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USARibas, Antoni论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA USA NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USAFlaherty, Keith论文数: 0 引用数: 0 h-index: 0机构: Harvard Med Sch, Canc Ctr, Massachusetts Gen Hosp, Ctr Melanoma, Boston, MA 02115 USA NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USAOsman, Iman论文数: 0 引用数: 0 h-index: 0机构: NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USA NYU, Interdisciplinary Melanoma Cooperat Grp, Sch Med, New York, NY 10016 USA NYU, Dept Med, Sch Med, New York, NY 10016 USA NYU, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USAWeber, Jeffrey论文数: 0 引用数: 0 h-index: 0机构: NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USA NYU, Interdisciplinary Melanoma Cooperat Grp, Sch Med, New York, NY 10016 USA NYU, Dept Med, Sch Med, New York, NY 10016 USA NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USAKirchhoff, Tomas论文数: 0 引用数: 0 h-index: 0机构: NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USA NYU, Dept Populat Hlth & Environm Med, Sch Med, New York, NY 10016 USA NYU, Interdisciplinary Melanoma Cooperat Grp, Sch Med, New York, NY 10016 USA NYU, Laura & Issac Perlmutter Canc Ctr, Sch Med, 522 First Ave, New York, NY 10016 USA